Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Open Price
31.40Prev. Close
30.7500Volume
463315.00Value
14330332.95Market Cap Cr
693.60
Price to Earnings
138.90
Price to Book Value
0.60
Dividend Yield
0.00
PE to Growth
1.20
Op Revenue TTM Cr
1685.63
Net Profit TTM Cr
4.99
Cash From Operating Activity Cr
224.69
Return on Equity %
0.46
EMA & SMA
Bullish Moving Averages
0
Bearish Moving Averages
16
DELIVERY AND VOLUME
04 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
31.58
Second Resistance
32.22
Third Resistance
32.65
First Support
30.51
Second Support
30.08
Third Support
29.44
Relative Strength Index
40.84
Money Flow Index
39.57
MACD
-0.43
MACD Signal
-0.3
Average True Range
1.23
Average Directional Index
16.63
Rate of Change (21)
6.29
Rate of Change (125)
-10.61
Commodity Channel Index
-91
Williams %R
-89
BETA
1 Month
1.35
3 Month
1.11
1 Year
0.94
3 Year
0.49
PRICE CHANGE ANALYSIS
1 Week
Low
High
30.5
32.33
1 Month
Low
High
26.15
34.74
3 Months
Low
High
26.15
38.8
6 Months
Low
High
26.15
45.7
1 Year
Low
High
19.8
45.7
NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith the certificate as per captioned regulationsNECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window
Notice of Closure of Trading Window as per attached letter.NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find attached herewith Annual Secretarial Compliance Report for the year ended on March 31, 2024NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the copy of newspapers for publication of financial results of the Company for the quarter and financial year ended on March 31, 2024.NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting - Reappointment of Cost Auditors and Secretarial AuditorsNECTAR LIFESCIENCES LTD. - 532649 - Audited Financial Results And Outcome Of Board Of Directors' Meeting
Audited Financial Results and outcome of Board MeetingNECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Intimation for Annual Audited Financial Results And Other Business Matters.
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2023-24, Financial Statements of the Company for the Financial Year 2023-24 and matters related thereto.NECTAR LIFESCIENCES LTD. - 532649 - Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached herewith disclosures as per captioned regulationsNECTAR LIFESCIENCES LTD. - 532649 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith the certificate as per captioned regulationsNECTAR LIFESCIENCES LTD. - 532649 - Compliance Under Regulation 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Please find attached herewith the Compliance Certificate as per captioned regulations.The latest market price of Nectar Lifesciences Ltd. on NSE was Rs. 30.93 as of today.
The opening share price of Nectar Lifesciences Ltd. was Rs. 31.40 as of today.
The 52-week high share price of Nectar Lifesciences Ltd. was Rs. 45.70.
The 52 week low share price of Nectar Lifesciences Ltd. was Rs. 19.80.
Nectar Lifesciences Ltd. has a market cap of Rs. 693.60 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Nectar Lifesciences Ltd. is 1.20. Please refer to the Fundamentals section for further details.
The operating revenue for Nectar Lifesciences Ltd. in the last FY was Rs. 1685.63 crore. Please refer to the Financials section for further details.
The Net Profit for Nectar Lifesciences Ltd. in the last FY was Rs. 4.99 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Nectar Lifesciences Ltd. was on 2020-09-11 for Rs. 0.05 per share. According to today’s share price, the dividend yield of Nectar Lifesciences Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Nectar Lifesciences Ltd. was as of 2008-11-12. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Nectar Lifesciences Ltd..